The relationship between YAP and the RAF/MEK/ERK cascade was discovered by genetic screens, which showed that the inhibitory combination of RAF or MEK with YAP has increased efficacy not only in BRAF-mutant cancers but also in KRAS-mutant cancers (67). This evidence concerns the gene BRAF and cancer.